Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |